Multi-day administration of the GLP-1 agonist, exendin-4, reduces food intake and body weight and prevents fasting related alterations in hypothalamic gene expression

Saved in:
Bibliographic Details
Published in:Appetite 2009-06, Vol.52 (3), p.861-861
Main Authors: Terrillion, C.E., Dailey, M.J., Tamashiro, K.L.K., Moran, T.H.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0195-6663
1095-8304
DOI:10.1016/j.appet.2009.04.191